New drug AUR103 calcium targets Hard-to-Treat neuroendocrine tumors
NCT ID NCT07640737
First seen Jun 11, 2026 · Last updated Jun 11, 2026
Summary
This phase 2 study tests a new drug, AUR103 calcium, in 30 adults with advanced neuroendocrine tumors that have worsened after at least one prior treatment. Participants take the drug twice daily until their disease gets worse or side effects become too severe. The main goal is to see if the drug shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE (NE) TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hoag Family Cancer Institute
Newport Beach, California, 92657, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic Cancer Center (MCCC)
Phoenix, Arizona, 85054, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic Cancer Center (MCCC)
Rochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic Hospital - Florida
Jacksonville, Florida, 32224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.